Incredible paper @JCardFail - "Hemodynamics for the HF Clinician: A State-of-the-Art Review". Important read for everyone interested in HF by Drs. Hsu, Fang & Borlaug - You'll learn a ton from this!
@HFSA #cardiotwitter @UUtah @hopkinsheart @MayoClinic
onlinejcf.com/article/S1071-โฆ
Robert Mentz, MD
4,139 posts
Co-Editor-in-Chief @JCardFail | Chief of the HF Section @DukeHealth | Trialist @DCRInews | Father of 3
- Grateful to share results of PARAGLIDE-HF on behalf of tremendous team effort. Sac/Val vs Val in 466 pts w HF and EF>40% with recent WHF. Positive trial for NTproBNP reduction; CV & renal endpts favored esp in EF<|=60% jacc.org/doi/10.1016/j.โฆ
- Excited to share that we've finished recruitment for the #TRANSFORM_HF Trial of Torsemide vs. Furosemide in HF So appreciative of all of the efforts by the site teams & for the participation of the patients! Stay Tuned for the Results! ๐๐ฝjacc.org/doi/10.1016/j.โฆ
- Congrats to @FudimMarat on his promotion to Associate Professor @dukemedicine - effective Nov 1 (today! ๐) An important recognition of your stellar achievements & ongoing work! @DukeHealth @manesh_patelMD @texhern @SvatiShah @JCardFail @dranulala @DrMarthaGulati
- Really nice State-of-the-Art Review on Balloon Pumps in HF - check this out: "IABP for Acute-on-Chronic HF Complicated by Cardiogenic Shock" @NavinKapur4 @ReshadGaranMD @dranulala @HFSA @ShashankSinhaMD @AndrewJSauer @FudimMarat @vbluml onlinejcf.com/article/S1071-โฆ
- Mechanistic Differences between Torsemide and Furosemide Prospective data debunks classic teachings ๐ตNo meaningful PK/PD advantages for T ๐ตKidney bioavailability less w T ๐ตRatio T:F was 4:1 (not 2:1!) ๐ตT w โฌ๏ธneurohormonal activ & kidney dysfunction journals.lww.com/jasn/abstract/โฆ
- Excited to serve the HF community. JCF has a rich history & promising future. Enhancing partnerships w @HFSA & its members. Focusing on research quality, team diversity & mentorship. Thx to my mentors @coconnormd @texhern @mfiuzat @DukeHFDoc @lmhcurtis @JRogersMD1 @manesh_patelMDWe are pleased to announce that Robert J. Mentz, MD has been named our new Editor-in-Chief. @robmentz will begin his term on Dec. 1. Welcome aboard, Dr. Mentz! Read the full press release >> hfsa.org/journal-cardiaโฆ @HFSA
- Congrats to the incoming @DukeCardFellows class! What a rockstar crew! Welcome to the @DukeHeartCenter Family!
- Yaโll, Iโm about to ๐คฏ Multiple new admit notes for pts w HFrEF with plan of โฆ โConsider spiro and SGLT2โ Can we start a global campaign to end the โconsiderโ?! Just do it! Start today - donโt delay! @gcfmd @SJGreene_md @MKIttlesonMD @dranulala @AndrewJSauer
- Lots of discussion about whether we should rec restricting sodium in pts w HF - What about fluid restriction?! Check out FRESH-UP Study Design Paper Fluid REStriction in Hf vs liberal fluid UPtake: Rationale & design of the randomised FRESH-UP study onlinejcf.com/article/S1071-โฆ
- Bittersweet news. @JRogersMD1 to leave @DukeCardiology to become President/CEO at Texas Heart Institute. Extraordinary clinician, researcher & mentor. He trained many & we're poised for continued growth w/ his focus - "patients first". Tremendous opportunity but he'll be missed
- Grateful to the incredible team who helped w TRANSFORM-HF - now published @JAMANetwork While torsemide wasn't superior to furosemide for survival in this patient pop, important insights for practice & future trials More to unpack on dose & hosp endpt jamanetwork.com/journals/jama/โฆ
- Honored to share this follow-up piece at JCF from @LGlaucomflecken May you find her words & guidance as impactful as we do "Words to Leave By: Bridges Out of the Quiet Place" @DGlaucomflecken @dranulala @HFSA @DrMarthaGulati @ShelleyZieroth @vbluml onlinejcf.com/article/S1071-โฆ





















